93 related articles for article (PubMed ID: 16110533)
1. The more things change..
Zuniga JM
IAPAC Mon; 2005 Mar; 11(3):60-1. PubMed ID: 16110533
[No Abstract] [Full Text] [Related]
2. [Reactions to the New York "supervirus". A challenge in primary resistance].
Paukstadt W
MMW Fortschr Med; 2005 Apr; 147 Spec No 1():86. PubMed ID: 16385890
[No Abstract] [Full Text] [Related]
3. HIV/AIDS. Experts question danger of 'AIDS superbug'.
Cohen J
Science; 2005 Feb; 307(5713):1185. PubMed ID: 15731415
[No Abstract] [Full Text] [Related]
4. A single case of multidrug-resistant HIV and rapid disease progression.
O'Rourke M
AIDS Clin Care; 2005 Mar; 17(3):21-2. PubMed ID: 15828115
[No Abstract] [Full Text] [Related]
5. Possible HIV "super-strain" in New York City; new human T-lymphotropic viruses identified in Africa.
Laurence J
AIDS Read; 2005 Apr; 15(4):155-6. PubMed ID: 15844234
[No Abstract] [Full Text] [Related]
6. [Epidemiology, physiopathology and therapeutic modalities of HIV infections].
Belan AG
Soins; 2009 Apr; (734):32-5. PubMed ID: 19475824
[No Abstract] [Full Text] [Related]
7. The probable source of both the primary multidrug-resistant (MDR) HIV-1 strain found in a patient with rapid progression to AIDS and a second recombinant MDR strain found in a chronically HIV-1-infected patient.
Blick G; Kagan RM; Coakley E; Petropoulos C; Maroldo L; Greiger-Zanlungo P; Gretz S; Garton T
J Infect Dis; 2007 May; 195(9):1250-9. PubMed ID: 17396993
[TBL] [Abstract][Full Text] [Related]
8. HIV drug resistance and you. Resistance testing in experienced patients. Considerations when changing drugs.
Posit Aware; 2006; Spec No():17-22. PubMed ID: 16596730
[No Abstract] [Full Text] [Related]
9. Profile of drug-resistant case in New York.
AIDS Patient Care STDS; 2005 May; 19(5):348. PubMed ID: 15945165
[No Abstract] [Full Text] [Related]
10. Slow accumulation of HIV resistance mutations: implications for resource-limited settings?
Stevens WS
J Infect Dis; 2009 Sep; 200(5):670-2. PubMed ID: 19604045
[No Abstract] [Full Text] [Related]
11. New drugs: the way forward.
Gazzard BG
J HIV Ther; 2001 Nov; 6(4):73-6. PubMed ID: 11740407
[No Abstract] [Full Text] [Related]
12. Why HIV drug resistance matters: an overview.
Learned J
Posit Aware; 2005; 16(5):26-30. PubMed ID: 16220604
[No Abstract] [Full Text] [Related]
13. Incidence of lamivudine resistance associated mutations in pol-gene of HIV-1 in patients from north India: a preliminary report.
Sachdeva N; Sehgal S; Sud A; Datta U; Arora SK
Indian J Pathol Microbiol; 2005 Jul; 48(3):337-40. PubMed ID: 16761745
[TBL] [Abstract][Full Text] [Related]
14. Guideline watch. Antiretroviral drug resistance testing--updated guidelines from the IAS-USA.
Hicks CB
AIDS Clin Care; 2008 Aug; 20(8):64. PubMed ID: 18814369
[No Abstract] [Full Text] [Related]
15. HIV drug resistance tests: an update on methods for calculating phenotypic fold change from a viral genotype.
Bellosillo NA; Bacheler L; Villacian J
Clin Infect Dis; 2009 Mar; 48(5):687; author reply 687. PubMed ID: 19191661
[No Abstract] [Full Text] [Related]
16. HIV genotypic resistance testing to optimize antiretroviral prescribing: is there room for improvement?
Uy J; Brooks JT; Baker R; Hoffman M; Moorman A; Novak R;
Antivir Ther; 2007; 12(6):957-62. PubMed ID: 17926650
[TBL] [Abstract][Full Text] [Related]
17. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.
Lima VD; Harrigan R; Murray M; Moore DM; Wood E; Hogg RS; Montaner JS
AIDS; 2008 Nov; 22(17):2371-80. PubMed ID: 18981777
[TBL] [Abstract][Full Text] [Related]
18. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
[TBL] [Abstract][Full Text] [Related]
19. Detection and significance of minority quasispecies of drug-resistant HIV-1.
Metzner KJ
J HIV Ther; 2006 Dec; 11(4):74-81. PubMed ID: 17578210
[No Abstract] [Full Text] [Related]
20. The V118I mutation as a marker of advanced HIV infection and disease progression.
Zaccarelli M; Tozzi V; Lorenzini P; Forbici F; Narciso P; Ceccherini-Silberstein F; Trotta MP; Bertoli A; Liuzzi G; Marconi P; Mosti S; Perno CF; Antinori A
Antivir Ther; 2007; 12(2):163-8. PubMed ID: 17503658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
